The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...
Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 ...
Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...
UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...
According to the Federal Trade Commission, UnitedHealth Group has been charging patients markups on lifesaving drugs. Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS ...
Health insurance companies gained today with shares of Humana Inc. ( NYSE:HUM ), UnitedHealth Group ( NYSE:UNH) and CVS ...
Shares of health insurance companies are trading higher after The Centers for Medicare and Medicaid Services proposed a rise ...
(Bloomberg) -- Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs, bringing ...